Clive E Handler
Overview
Explore the profile of Clive E Handler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan J, Condliffe R, Dimopoulos K, et al.
J Heart Lung Transplant
. 2017 Feb;
36(7):770-779.
PMID: 28190786
Background: Portopulmonary hypertension (PoPH) is a rare condition associated with poor survival, and the effect of modern therapies that target pulmonary arterial hypertension (PAH) on long-term outcome is unknown. This...
2.
Sobanski V, Giovannelli J, Lynch B, Schreiber B, Nihtyanova S, Harvey J, et al.
Arthritis Rheumatol
. 2015 Sep;
68(2):484-93.
PMID: 26415038
Objective: Pulmonary arterial hypertension (PAH) is a severe complication of connective tissue diseases (CTDs). This study aimed to investigate the clinical and hemodynamic characteristics and survival of anti-U1 RNP-positive patients...
3.
Valerio C, Schreiber B, E Handler C, Denton C, Coghlan J
Arthritis Rheum
. 2013 Jan;
65(4):1074-84.
PMID: 23280155
Objective: To determine whether patients with systemic sclerosis (SSc) and borderline mean pulmonary artery pressure (PAP) at cardiac catheterization are more likely to develop pulmonary hypertension (PH) than those in...
4.
Valerio C, E Handler C, Kabunga P, Smith C, Denton C, Coghlan J
Rheumatology (Oxford)
. 2010 Aug;
49(11):2147-53.
PMID: 20675359
Objectives: To report outcomes in patients with CTD-pulmonary arterial hypertension (CTD-PAH) in an observational cohort treated with bosentan or sitaxentan and determine whether differences would justify a randomized, controlled multicentre...
5.
Williams M, E Handler C, Akram R, Smith C, Das C, Smee J, et al.
Eur Heart J
. 2006 May;
27(12):1485-94.
PMID: 16682379
Aims: The aims of this study were to evaluate the diagnostic value and to explore the prognostic value of N-terminal brain natriuretic peptide (N-TproBNP) in patients with systemic sclerosis (SSc)...